Investor profile
Entropia Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Entropia Capital builds and backs frontier technology companies shaping the future of critical industries, operating at the intersection of deep technology, industrial infrastructure, and international execution. The firm helps complex scientific and engineering breakthroughs scale into globally relevant businesses by aligning capital, operational expertise, and ecosystem access — supporting companies navigating markets where regulation, manufacturing, and commercialization evolve simultaneously. Unlike traditional venture capital models built around extreme power-law assumptions and very long holding periods, Entropia Capital operates with a more operational, flexible, and execution-driven investment approach. It primarily invests in frontier and deep technology companies at the pre-seed, seed, and Series A stages — often before the market has fully recognized the strategic value of the underlying technology — across healthcare, advanced materials, robotics, climate infrastructure, digital assets, industrial AI, neurotechnology, and computational biology. The firm's philosophy is encapsulated in: "Capital is the anchor. Execution is the multiplier. Education is the moat."
Notable quotes
“We keep our heads down and obsess over how we can help entrepreneurs build great businesses. We are the blue-collar operators that keep showing up every morning to get after it.”
“At Entropia Capital, which also operates in the US and Europe, we've seen this shift firsthand: fewer IPO ambitions, more capital-efficient startups, and leaner funds deploying smarter capital. The era of blitzscaling on cheap money is over, and that's a welcome evolution.”
“From where we sit at Entropia Capital, the current investment environment makes this even clearer. Despite real progress, being a founder in Southeast Asia still doesn't carry the cultural or economic weight it does in the US, Europe, China, or India.”
Team
Andreea Radulescu
Venture Partner
Cédric Barrier
Managing Partner
Foghor Kagho
Operating Partner
Sean Ang
Venture Partner
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Mindsigns Health | Pre-seed | — | 2024-12 |
| BrainEver | Seed | — | — |
| Vetbiolix | Seed | — | — |
| EkWateur | Seed | — | — |
| Zama | Seed | — | — |
| Trust For Good | Pre-seed | — | — |
| Serendip Innovations | Pre-seed | — | — |
Fit check
Is Entropia Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit